A bottom-line case for moving your lens finishing in-house

Article

Spectacle lens sales, excluding frames, generate about the same annual revenue as eye exams, yet are often an afterthought for many busy practices.

Spectacle lens sales, excluding frames, generate about the same annual revenue as eye exams, yet are often an afterthought for many busy practices. Adding in-office finishing can help maximize revenues, Mike Rothschild, OD, said.

Although two-thirds of patients see an optometrist for eye exams, three or four out of every 10 leave the office to purchase eyewear elsewhere, according to Dr. Rothschild. "In a practice with $750,000 annual gross revenue and an average eyewear capture rate of 61%, $160,000 in revenue walks out the door each year," he said.

Factors to consider

Compare the costs of the outsourcing business model to those of the in-office model by calculating monthly outsourcing costs, in-office finishing costs, insurance reimbursements, and in-office finishing savings. The result will be an estimate of the annual margin from in-office finishing.

In the financial analysis, remember to balance the cost of a major purchase, such as an edger, with new revenue. But generating that new revenue will cost money, and the formula doesn't work if both inputs are equal. Dr. Rothschild recommended that you plan to generate up to twice as much revenue as any new expense-$1,500 to $2,000 in revenue for a $1,000 cost.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, expresses excitement for emerging retinal therapies
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
Steven Ferrucci, OD, FAAO, at Controversies in Modern Eyecare 2025
At CIME 2025, Selina McGee, OD, FAAO, says some patients underestimate oculoplastic care. She stands in front of a sign that says Controversies in Modern Eye Care 2025.
Patricia Buehler, MD, MPH, at ASCRS 2025
Brett Bielory, MD, at ASCRS 2025
© 2025 MJH Life Sciences

All rights reserved.